Email
Print
Microkeratome Market Overview:
Microkeratome Market is projected to expand significantly, with an estimated size of $1.3 Billion by 2030. This growth is expected to occur at a compound annual growth rate CAGR of 10.4% during the forecast period from 2023 to 2030. The microkeratome market is a rapidly growing segment within the ophthalmic industry. A microkeratome is a surgical instrument used in procedures such as LASIK (Laser-Assisted In Situ Keratomileusis) to create a thin flap in the cornea for vision correction. The market is primarily driven by the increasing prevalence of refractive errors and the growing demand for minimally invasive ophthalmic surgeries.
Technological advancements in microkeratome devices, such as the introduction of bladeless or femtosecond laser-assisted systems, have significantly improved surgical outcomes and patient safety. These advancements have led to a surge in the adoption of microkeratomes by ophthalmologists worldwide.
Moreover, the rising disposable incomes and increasing awareness about the benefits of vision correction surgeries are contributing to the market's expansion. Key market players are focusing on research and development activities to introduce innovative and efficient microkeratome systems.
However, the market also faces challenges such as the high cost of procedures and the availability of alternative technologies like photorefractive keratectomy (PRK) and implantable contact lenses. Nonetheless, with ongoing technological advancements and a growing number of patients seeking vision correction, the microkeratome market is expected to continue its growth trajectory in the foreseeable future.
Market Snapshot:
Microkeratome Market - Report Coverage:
The “Microkeratome Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Microkeratome Market.
| Attribute | Segment |
|---|---|
By Type |
|
By Application |
|
By Distribution Channel |
|
By Geography |
|
Microkeratome Market - Top Trends
1. Technological Advancements: The microkeratome market is witnessing significant advancements in technology, particularly with the introduction of bladeless or femtosecond laser-assisted systems. These innovative devices offer improved precision, safety, and better surgical outcomes, driving their adoption in the market.
2. Increasing Demand for Minimally Invasive Surgeries: There is a growing preference among patients and surgeons for minimally invasive procedures. Microkeratomes provide a less invasive alternative to traditional surgical methods, leading to faster recovery times and reduced risks. This trend is contributing to the growth of the microkeratome market.
3. Rising Prevalence of Refractive Errors: The increasing incidence of refractive errors, such as myopia, hyperopia, and astigmatism, is driving the demand for vision correction surgeries. According to International Myopia Institute, 30% of the world is currently myopic and by 2050, almost 50% will be myopic, that’s a staggering 5 billion people. Microkeratomes are widely used in procedures like LASIK to reshape the cornea and correct these refractive errors, leading to improved vision. This trend is bolstering the microkeratome market growth.
4. Focus on Research and Development: Key market players are investing in research and development activities to introduce more advanced and efficient microkeratome systems. This includes improving the ergonomics, enhancing safety features, and incorporating intelligent automation. These efforts are aimed at meeting the evolving needs of surgeons and patients and gaining a competitive edge in the market.
The Microkeratome Market - Company Analysis
Alcon, Inc.: Alcon is a leading global company specializing in eye care products and devices. They offer the Alcon FS200 Femtosecond Laser, a bladeless microkeratome system known for its precise corneal flap creation in LASIK procedures. Alcon has a strong presence in the market, supported by their extensive product portfolio and global distribution network.
Bausch + Lomb: Bausch + Lomb is a renowned eye health company known for its innovative ophthalmic products. Their VICTUS Femtosecond Laser Platform offers high precision in corneal flap creation for LASIK and other ophthalmic procedures. Bausch + Lomb's strong brand reputation and commitment to research and development contribute to their market position.
Carl Zeiss Meditec AG: Carl Zeiss Meditec is a leading provider of medical technology solutions for various ophthalmic applications. Their VisuMax Femtosecond Laser System is a compact and user-friendly device that enables precise corneal flap creation. The company's technological expertise and focus on delivering advanced solutions drive their market presence.
NIDEK CO., LTD.: NIDEK is a global company specializing in the development and manufacturing of ophthalmic equipment. Their EC-5000 Excimer Laser System incorporates a microkeratome for corneal flap creation in LASIK surgeries. NIDEK's commitment to innovation and product quality has established them as a key player in the microkeratome market.
Ziemer Ophthalmic Systems AG: Ziemer Ophthalmic Systems is a Swiss-based company known for its advanced ophthalmic surgical solutions. Their LDV Z8 Femtosecond Laser is a versatile platform used for corneal surgeries, including microkeratome-assisted LASIK. Ziemer's focus on precision, safety, and technological advancements contributes to their market position.
WaveLight GmbH (Alcon): WaveLight GmbH, a subsidiary of Alcon, specializes in refractive surgery solutions. Their Allegretto Wave Eye-Q Excimer Laser System is often used in conjunction with microkeratome systems for LASIK procedures. WaveLight's expertise in refractive surgery technologies bolsters their presence in the microkeratome market.
SCHWIND eye-tech-solutions GmbH: SCHWIND eye-tech-solutions is a German company dedicated to developing innovative refractive and therapeutic ophthalmic solutions. They offer microkeratome systems as part of their comprehensive refractive surgery portfolio. SCHWIND's strong focus on research, development, and clinical expertise contributes to their market position.
ZEISS Group: ZEISS is a global technology company that operates in various sectors, including medical technology. Their MEL 90 Excimer Laser System is often used in conjunction with microkeratome systems for LASIK surgeries. ZEISS's reputation for precision optics and advanced technologies supports their presence in the microkeratome market.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies players in the Microkeratome Market adopt. The top 10 companies in Microkeratome Market are listed below:
1. Abbott Medical Optics Inc.
2. STAAR Surgical Company
3. Alcon, Inc.
4. Bausch & Lomb Incorporated
5. Novartis AG
6. Nidek Co., Ltd.
7. Ziemer Ophthalmic Systems AG
8. FCI Ophthalmics
9. CooperVision
10. Johnson & Johnson Vision Care
Scope of the Report:
| Report Metric | Details |
|---|---|
Base Year Considered | 2023 |
Forecast Period | 2023–2030 |
CAGR | 10.4% |
Market Size in 2030 | $ 1.3 Billion |
Segments Covered | By Type, Treatment, Distribution Channel and Region |
Geographies Covered | North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
Key Market Players |
|
For more Information and Communications Technology Market reports, please Click Here
1.Microkeratome Market Overview
1.1 Definitions and Scope
2. Microkeratome Market– Executive Summary
3. Microkeratome Market– Market Landscape
3.1 Company Benchmarking – Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis – Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Microkeratome Market– Startup Company Scenario
4.1 Investment
4.2 Revenue
4.3 Venture Capital and Funding Scenario
5. Microkeratome Market– Market Entry Scenario Premium
5.1 Regulatory Scenario
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Microkeratome Market– Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porter’s Five Force Model
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Powers of Customers
6.3.3 Threat of New Entrants
6.3.4 Rivalry Among Existing Players
6.3.5 Threat of Substitutes
7. Microkeratome Market– Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle Analysis
8. Microkeratome Market– By Type (Market Size - $Million/$Billion)
8.1 Reusable
8.1.1 Market Trends by Region
8.1.2. Market Size & Forecast by Region
8.2 Disposable
8.2.1 Market Trends by Region
8.2.2 Market Size & Forecast by Region
9. Microkeratome Market– by Application (Market Size - $Million/$Billion)
9.1 Epiretinal Membrane
9.1.1 Market Trends & Forecast by Region
9.1.2 Market Size & Forecast by Region
9.2 Diabetic Retinopathy
9.2.1 Market Trends by Region
9.2.2 Market Size & Forecast by Region
9.3 Retinal Detachment
9.3.1 Market Trends by Region
9.3.2 Market Size & Forecast by Region
9.4 Others
9.4.1 Market Trends by Region
9.4.2 Market Size & Forecast by Region
10. Microkeratome Market– by Distribution Channel (Market Size - $Million/$Billion)
10.1 Hospitals
10.2 Ophthalmic Clinics
10.2.1 Market Trends by Region
10.2.2 Market Share & Forecast by Region
10.3 Online Retailers
10.3.1 Market Trends by Region
10.3.2 Market Share & Forecast by Region
10.4 Authorized Distributors
10.4.1 Market Trends by Region
10.4.2 Market Size & Forecast by Region
10.5 Others
10.5.1 Market Trends by Region
10.5.2 Market Size & Forecast by Region
11 Microkeratome Market– by Distribution Channel (Market Size - $Million/$Billion)
11.1 Hospitals
11.1.1 Market Trends by Region
11.1.2 Market Size & Forecast by Region
11.2 Ophthalmic Clinics
11.2.1 Market Trends by Region
11.2.2 Market Size & Forecast by Region
11.3 Online Retailers
11.3.1 Market Trends by Region
11.3.2 Market Size & Forecast by Region
11.4 Authorized Distributors
11.4.1 Market Trends by Region
11.4.2 Market Size & Forecast by Region
12 Microkeratome Market– by Geography (Market Size - $Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.1.3 Mexico
12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 U.K.
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia-Pacific
12.3.1 China
12.3.2 Japan
12.3.3 South Korea
12.3.4 India
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia-Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Chile
12.4.4 Colombia
12.4.5 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13 Microkeratome Market– Market Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Microkeratome Market– Industry Competition Landscape
14.1 Market Share Analysis
14.1.1 Market Share by Technology – Key Companies
14.1.2 Market Share by Country – Key Companies
14.1.3 Market Share by Region – Key Companies
14.2 Competition Matrix
14.3 Best Practices for Companies
15 Microkeratome Market– Key Company List by Country Premium
16 Microkeratome Market– Company Analysis
16.1 EssilorLuxottica
16.2 Marvel
16.3 Novartis AG
16.4 HAAG-Streit Holding AG
16.5 Nidek Co., Ltd.
16.6 Topcon Corporation
16.7 Valeant Pharmaceuticals International, Inc.
16.8 Ziemer Ophthalmic Systems AG
16.9 Sonomed Escalon
16.10 Gulden Ophthalmics
16.11 FCI Ophthalmics
16.12 Glaukos Corporation
* "Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized
reports that best suit your requirements. Our reports include global-level
data, niche markets and competitive landscape.
The Microkeratome Market is forecast to grow at 10.4% during the forecast period 2023-2030.
Microkeratome Market size is estimated to be $1.3 Billion in 2030
Top companies in the Microkeratome Market are Valeant Pharmaceuticals International, Inc, Ziemer Ophthalmic Systems AG, FCI Ophthalmics, and others.